Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Shinsuke Yasuda, Kazumasa Ohmura, Hiroshi Kanazawa, Takashi Kurita, Yujiro Kon, Tomonori Ishii, Yuichiro Fujieda, Satoshi Jodo, Kazuhide Tanimura, Michio Minami, Tomomasa Izumiyama, Takumi Matsumoto, Yoshiharu Amasaki, Yoko Suzuki, Hideki Kasahara, Naofumi Yamauchi, Masaru Kato, Tamotsu Kamishima, Akito Tsutsumi, Hiromitsu Takemori, Takao Koike & Tatsuya Atsumi. (2017) Maintenance treatment using abatacept with dose reduction after achievement of low disease activity in patients with rheumatoid arthritis (MATADOR) – A prospective, multicenter, single arm pilot clinical trial. Modern Rheumatology 27:6, pages 930-937.
Read now
Read now
Tomoya Hirota, Takeshi Suzuki, Hiroshi Ogishima, Shinya Hagiwara, Hiroshi Ebe, Hiroyuki Takahashi, Masahiro Yokosawa, Naoto Umeda, Yuya Kondo, Hiroto Tsuboi, Isao Matsumoto & Takayuki Sumida. (2016) Evaluation of changes in magnetic resonance images following 24 and 52 weeks of treatment of rheumatoid arthritis with infliximab, tocilizumab, or abatacept. Modern Rheumatology 26:1, pages 29-35.
Read now
Read now
Koichi Amano, Tsukasa Matsubara, Takaaki Tanaka, Hiroshi Inoue, Mitsuhiro Iwahashi, Toshihisa Kanamono, Teruaki Nakano, Shoichi Uchimura, Tomomaro Izumihara, Akira Yamazaki, Chetan S. Karyekar & Tsutomu Takeuchi. (2015) Long-term safety and efficacy of treatment with subcutaneous abatacept in Japanese patients with rheumatoid arthritis who are methotrexate inadequate responders. Modern Rheumatology 25:5, pages 665-671.
Read now
Read now
Tsutomu Takeuchi, Nobuyuki Miyasaka, Shinichi Kawai, Naonobu Sugiyama, Hirotoshi Yuasa, Noriaki Yamashita, Noriko Sugiyama, Lorin Craig Wagerle, Bonnie Vlahos & Joseph Wajdula. (2015) Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials. Modern Rheumatology 25:2, pages 173-186.
Read now
Read now
Mitsuhiro Iwahashi, Hiroshi Inoue, Tsukasa Matsubara, Takaaki Tanaka, Koichi Amano, Toshihisa Kanamono, Teruaki Nakano, Shoichi Uchimura, Tomomaro Izumihara, Akira Yamazaki, Chetan S. Karyekar & Tsutomu Takeuchi. (2014) Efficacy, safety, pharmacokinetics and immunogenicity of abatacept administered subcutaneously or intravenously in Japanese patients with rheumatoid arthritis and inadequate response to methotrexate: a Phase II/III, randomized study. Modern Rheumatology 24:6, pages 885-891.
Read now
Read now
Tsutomu Takeuchi, Tsukasa Matsubara, Yukitomo Urata, Eiichi Suematsu, Shuji Ohta, Shigeru Honjo, Tohru Abe, Ami Yamamoto & Nobuyuki Miyasaka. (2014) Phase III, multicenter, open-label, long-term study of the safety of abatacept in Japanese patients with rheumatoid arthritis and an inadequate response to conventional or biologic disease-modifying antirheumatic drugs. Modern Rheumatology 24:5, pages 744-753.
Read now
Read now
Yoshiya Tanaka, Satoshi Kubo, Hisashi Yamanaka, Koichi Amano, Shintaro Hirata, Eiichi Tanaka, Hayato Nagasawa, Hidekata Yasuoka & Tsutomu Takeuchi. (2014) Efficacy and safety of abatacept in routine care of patients with rheumatoid arthritis: Orencia® as Biological Intensive Treatment for RA (ORBIT) study. Modern Rheumatology 24:5, pages 754-762.
Read now
Read now
Nozomi Iwanaga, Tomoki Origuchi, Kaoru Terada, Yukitaka Ueki, Yasuhiro Kamo, Noboru Kinoshita, Nobuhisa Yonemitsu, Shin-Ya Kawashiri, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura & Atsushi Kawakami. (2014) Rheumatoid arthritis complicated with severe liver injury during treatment with abatacept. Modern Rheumatology 24:5, pages 874-876.
Read now
Read now
Articles from other publishers (17)
Penghua Shi, Li Wang, Jiafang He & Yun Lu. (2023) Comparative Efficacy of bDMARDs and tsDMARDs for the Treatment of Rheumatoid arthritis: A Systematic Review and Network Meta-Analysis. International Journal of Biology and Life Sciences 3:1, pages 35-42.
Crossref
Crossref
Eri Sugano, Eiichi Tanaka, Eisuke Inoue, Ryoko Sakai, Mai Abe, Kumiko Saka, Naohiro Sugitani, Moeko Ochiai, Rei Yamaguchi, Yoko Higuchi, Naoki Sugimoto, Katsunori Ikari, Ayako Nakajima, Hisashi Yamanaka & Masayoshi Harigai. (2022) Differences in patients’ population and efficacy/effectiveness of biologic disease–modifying antirheumatic drugs between randomized controlled trials and real-world settings in patients with rheumatoid arthritis – using the IORRA cohort. Modern Rheumatology 32:4, pages 675-685.
Crossref
Crossref
Mingcai Wu, Mengjun Tao, Quanhai Wang, Xiaohua LuHui Yuan. (2021) Fusion proteins of biologic agents in the treatment of rheumatoid arthritis (RA). Medicine 100:24, pages e26350.
Crossref
Crossref
Jennie H. Best, Yuting Kuang, Yilin Jiang, Rajpal Singh, Andreas Karabis, Jennifer Uyei, Joseph Dang & William G. Reiss. (2021) Comparative Efficacy (DAS28 Remission) of Targeted Immune Modulators for Rheumatoid Arthritis: A Network Meta-Analysis. Rheumatology and Therapy 8:2, pages 693-710.
Crossref
Crossref
Catherine Dostert, Melanie Grusdat, Elisabeth Letellier & Dirk Brenner. (2019) The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond. Physiological Reviews 99:1, pages 115-160.
Crossref
Crossref
Tsukasa Matsubara, Hiroshi Inoue, Toshihiro Nakajima, Kazuhide Tanimura, Akira Sagawa, Yukio Sato, Kei Osano, Shuji Nagano, Yukitaka Ueki, Tadamasa Hanyu, Koichi Hashizume, Norihito Amano, Yoshiya Tanaka & Tsutomu Takeuchi. (2018) Abatacept in combination with methotrexate in Japanese biologic-naive patients with active rheumatoid arthritis: a randomised placebo-controlled phase IV study. RMD Open 4:2, pages e000813.
Crossref
Crossref
Jasvinder A Singh, Alomgir Hossain, Amy S Mudano, Elizabeth Tanjong Ghogomu, Maria E Suarez-Almazor, Rachelle Buchbinder, Lara J Maxwell, Peter Tugwell & George A Wells. (2017) Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Hitoshi Tokuda, Masayoshi Harigai, Hideto Kameda, Kazunori Tomono, Noboru Takayanagi, Akira Watanabe, Sadatomo Tasaka, Takafumi Suda, Kazuhiro Tateda & Junichi Kadota. (2017) Consensus statements for medical practice: Biological agents and lung disease [Abridged English translation by the Japanese Respiratory Society]. Respiratory Investigation 55:3, pages 229-251.
Crossref
Crossref
Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Amy S Mudano, Lara J Maxwell, Rachelle Buchbinder, Maria Angeles Lopez-Olivo, Maria E Suarez-Almazor, Peter Tugwell & George A Wells. (2017) Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews 2017:3.
Crossref
Crossref
Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Amy S Mudano, Peter Tugwell & George A Wells. (2016) Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA). Cochrane Database of Systematic Reviews 2016:11.
Crossref
Crossref
Glen S Hazlewood, Cheryl Barnabe, George Tomlinson, Deborah Marshall, Daniel JA Devoe & Claire Bombardier. (2016) Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis. Cochrane Database of Systematic Reviews 2016:8.
Crossref
Crossref
Yehong Wang, Rui Zhu, Jim Xiao, John C. DavisJrJr, Jaap W. Mandema, Jin Y. Jin & Meina T. Tang. (2015) Short‐Term Efficacy Reliably Predicts Long‐Term Clinical Benefit in Rheumatoid Arthritis Clinical Trials as Demonstrated by Model‐Based Meta‐Analysis. The Journal of Clinical Pharmacology 56:7, pages 835-844.
Crossref
Crossref
Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Ahmed Kotb, Robin Christensen, Amy S Mudano, Lara J Maxwell, Nipam P Shah, Peter Tugwell & George A Wells. (2016) Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews 2016:5.
Crossref
Crossref
T. Takeuchi, T. Matsubara, S. Ohta, M. Mukai, K. Amano, S. Tohma, Y. Tanaka, H. Yamanaka & N. Miyasaka. (2014) Biologic-free remission of established rheumatoid arthritis after discontinuation of abatacept: a prospective, multicentre, observational study in Japan. Rheumatology 54:4, pages 683-691.
Crossref
Crossref
Wei Fan, Dong-bao Zhao, Shao-Xian Hu, Hu-ji Xu, Xiao Zhang, Miu-jia Zhang, Zhi-wei Chen, Feng-xiao Zhang, Ping Zhu, Xin-fu Li, Li-qi Bi, Bin Zhou & Chun-de Bao. (2014) A randomized, double-blind, and placebo-controlled multicenter clinical trial of a novel cytotoxic T-lymphocyte antigen-4 fusion protein, Leining, in Chinese active rheumatoid arthritis patients with an inadequate response to methotrexate. Rheumatology International 34:11, pages 1519-1527.
Crossref
Crossref
Petra Baji, Márta Péntek, László Czirják, Zoltán Szekanecz, György Nagy, László Gulácsi & Valentin Brodszky. (2014) Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison. The European Journal of Health Economics 15:S1, pages 53-64.
Crossref
Crossref
Yuko Kaneko & Tsutomu Takeuchi. (2014) A Paradigm Shift in Rheumatoid Arthritis over the Past Decade. Internal Medicine 53:17, pages 1895-1903.
Crossref
Crossref